Form 4: Priority Technology Holdings Director John Priore Reports Stock Transactions
SEC Form 4 Filing
Director John Priore reports acquisition and disposal of Priority Technology Holdings common stock on January 2, 2025, including shares withheld for tax obligations.
Summary
- On January 2, 2025, John Priore, a director and 10% owner of Priority Technology Holdings, engaged in transactions involving the company's common stock.
- Priore acquired 7,985 shares of common stock through the vesting of restricted stock units.
- Concurrently, Priore disposed of 2,555 shares to satisfy tax obligations at a price of $11.75 per share.
- Following these transactions, Priore beneficially owns 8,769,005 shares of Priority Technology Holdings common stock.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor potential shifts in ownership and alignment of interests.
Stakeholder Impact
- Shareholders can use this information to understand the actions of a key insider, which may influence their investment decisions.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Reporting Person was granted 31,949 restricted stock units which vest 25% on April 1, 2024, 25% on July 1, 2024, 25% on October 1, 2024, and 25% on January 1, 2025 subject to the Reporting Person's continued service as a director of the Issuer. |
| 04/01/2024 | 25% of 31,949 restricted stock units vest. |
| 07/01/2024 | 25% of 31,949 restricted stock units vest. |
| 10/01/2024 | 25% of 31,949 restricted stock units vest. |
| 01/01/2025 | 25% of 31,949 restricted stock units vest. |
| 01/02/2025 | Priore acquired 7,985 shares of common stock through the vesting of restricted stock units and disposed of 2,555 shares to satisfy tax obligations at a price of $11.75 per share. |
| 01/06/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.